Phoenix, Ariz. (November 1, 2022) – CashLabs LLC, a Tucson Arizona based national laboratory platform, announced the acquisition of Beacon Biomedical, a Phoenix Arizona based CLIA accredited medical laboratory focused on the development and commercialization of early detection cancer screening tests.Continue reading
Author Archive: AZBio
Crispr in diagnostics will be a revolution . . . eventually.
Two years ago this month, the Nobel Prize in Chemistry was awarded to two of the pioneers of the Crispr DNA-editing technique. Since then, it has displaced all other laboratory techniques for that purpose by virtue of its accuracy, simplicity, ease of use, and low cost.
How it works and why it was Nobel-worthyContinue reading
BIO and AZBio 2022 Reports Illustrate Bioindustry Impact
The Biotechnology Innovation Organization (BIO) and the Council of State Bioscience Associations (CSBA) today released new data on the bioscience industry in the United States. The report includes individual fact sheets for all 50 states, the District of Columbia and Puerto Rico, which can be found alongside the full report and interactive map at www.bio.org/jobs. AZBio uses this data and additional federally reported data to build its statewide progress report.
UArizona researchers develop ‘Goldilocks drug’ to treat triple-negative breast cancer
University of Arizona researchers have been working for decades to develop a drug that so specifically targets a deadly kind of breast cancer that there are little to no toxic side effects.Continue reading
NeoLight acquires first-of-its-kind musical pacifier technology for premature babies
SCOTTSDALE, Ariz., Oct. 25, 2022 /PRNewswire/ — NeoLight has signed an agreement to acquire the Pacifier Activated Lullaby (PAL®) System by Powers Medical Inc., a US-based medical technology company that focuses on musical therapy in the newborn baby market. This acquisition strengthens the NeoLight neonatal portfolio by introducing a solution for two growing concerns in newborn care; Non-nutritive sucking (NNS) and Neonatal Abstinence Syndrome (drug-addicted babies).Continue reading
Aesthetics Biomedical ® Inc. Announces FDA Clearance of Vivace Ultra™, The First-and-Only Personalized Radiofrequency (RF) Microneedling Technology
Revolutionizing treatments with unmatched precision and visionContinue reading
ASU researcher advances the science of protein sequencing with NIH Innovator Award
Chao Wang, a researcher with the Biodesign Center for Molecular Design and Biomimetics at Arizona State University, and his colleagues are advancing an ambitious project: developing new methods for sequencing individual protein molecules using a rapid, accurate and inexpensive methodContinue reading
The IRA is now law. What comes next?
AZBio President & CEO, Joan Koerber-Walker provides a brief overview of the provision of the Inflation Reduction act of 2022 (The IRA) from the patient and health innovation perspective and is then joined by health innovator and drug developer, Dr. Steven J. Potts, for a discussion of the potential unintended consequences of some provisions of The IRA relating to the future health innovation landscape.Continue reading
The Tissue Reference Group at the FDA, Recognizes BioLab Sciences Membrane Wrap – Hydro™ as an HCT/P
The unique amniotic membrane allograft aids in the covering and protection of wounds
Dr. Curiel-Lewandrowski Accepted into Leadership Fellowship
Clara Curiel-Lewandrowski, MD, FAAD, professor of medicine and chief of the Division of Dermatology in the UArizona College of Medicine – Tucson has been accepted into the Hedwig van Ameringen Executive Leadership in Academic Medicine (ELAM) program.Continue reading